Image

Global Diabetes Pen Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jun 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
  • Healthcare
  • Upcoming Report
  • Jun 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Diabetes Pen Market, By Product Type (Insulin Pens, Insulin Pen Needle), Usage (Reusable Pens, Disposable Pens), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Diabetes Pen Market Market Analysis and Insights of Diabetes Pen Market

Diabetes pen market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 8.95% in the above mentioned forecast period.

The diabetes pens are largely used to inject insulin for the treatment of diabetes. It is basically composed of an insulin cartridge which is incorporated or bought separately and a dial to quantify the dose, and is also used with disposable pen needles to deliver the dose.

The rise in the population of diabetes patients across the globe is amongst the important factor expected to intensify the growth and demand of diabetes pen market. In addition, the high demand for human insulin analogue and rise in the incidence of needle stick injury are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the reimbursement for diabetes management and rapid technological advancement in production of diabetes pens are also likely to enhance the growth of the market. Furthermore, the rise in the particular treatments for cancer along with easy access to large proportion of medicines are also amongst the significant factors expected to fuel the growth of the diabetes pen market.

The rapid advancements in technologies rise in the research and development and the rise in the popularity of reusable insulin pen among consumers due to their low cost over disposable pens are anticipated to offer significant growth opportunities for the diabetes pen market in the forecast period of 2021 to 2028.

However, the various safety issues related to usage and strict rules for new products development are expected to curb the growth of the diabetes pen market, whereas the advancements of new products in the healthcare industry and poor reimbursement scenario in developing countries can challenge the growth of the diabetes pen market.

This diabetes pen market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on diabetes pen market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Diabetes Pen Market Scope and Market Size

Diabetes pen market is segmented on the basis of product type, usage, application and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • The product type segment of the diabetes pen market is segmented into insulin pens and insulin pen needle.
  • Based on usage, the diabetes pen market is segmented into reusable pens and disposable pens.
  • On the basis of application, the diabetes pen market is segmented into type 1 diabetes and type 2 diabetes.
  • On the basis of distribution channel, the diabetes pen market is segmented into hospital pharmacy, retail pharmacy, online sales and diabetes clinics.

Diabetes Pen Market Country Level Analysis

Diabetes pen market is analyzed and market size insights and trends are provided by country, product type, usage, application and distribution channel as referenced above.

The countries covered in the diabetes pen market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the diabetes pen market owing to the rise in the diabetic population and better awareness and reimbursement policy for diabetes management. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the healthcare infrastructure, rise in the awareness, large patient pool and increase in the healthcare expenditure. 

The country section of the diabetes pen market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Diabetes pen market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for diabetes pen market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diabetes pen market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Diabetes Pen Market Share Analysis

Diabetes pen market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to diabetes pen market.

The major players covered in the diabetes pen market report are AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, Jiangsu Delfu medical device Co., Ltd., Owen Mumford., Wockhardt Limited (India), Smiths Group plc, Nipro Europe Group Companies, Novo Nordisk India Pvt Ltd., InjexUK, Mannkind Corporation, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Copernicus, Ypsomed AG, HTL-STREFA S.A., Merck & Co., Inc., and Bayer AG among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions

The Diabetes Pen Market is projected to grow at a CAGR of 8.95% during the forecast period by 2030.
The Diabetes Pen Market is segmented on the basis of product type, usage, application and distribution channel.
The major players in the Diabetes Pen Market are AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, Jiangsu Delfu medical device Co., Ltd., Owen Mumford., Wockhardt Limited (India), Smiths Group plc, Nipro Europe Group Companies, etc.
The countries covered in the Diabetes Pen Market are U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, Poland, Sweden, Denmark, Rest of Europe, Japan, China, South Korea, India, Australia and New Zealand, etc.